Sectoral Asset Management’s Contineum Therapeutics CTNM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.25M Sell
689,587
-38,000
-5% -$566K 5.88% 2
2026
Q2
$11.9M Hold
727,587
– – 8.32% 1
2026
Q1
$9.5M Sell
727,587
-73,200
-9% -$982K 7.87% 2
2025
Q4
$9.15M Hold
800,787
– – 7.34% 2
2025
Q3
$9.41M Hold
800,787
– – 5.81% 1
2025
Q2
$3.18M Hold
800,787
– – 2.1% 5
2025
Q1
$5.59M Hold
800,787
– – 4.35% 5
2024
Q4
$11.7M Sell
800,787
-100
-0% -$1.58K 7.83% 2
2024
Q3
$15.3M Hold
800,887
– – 9.05% 2
2024
Q2
$14.1M Buy
+800,887
New +$12.9M 5.73% 3

Other funds holding CTNM

Sectoral Asset Management's CTNM Position: Q3 2026 in Review

Sectoral Asset Management reduced its Contineum Therapeutics (CTNM) stake by 5.2% in Q3 2026, selling an estimated $566K and leaving 689,587 shares worth $9.25M. The position accounts for 5.88% of the portfolio, ranked #2.

Sectoral Asset Management first reported a position in CTNM in Q2 2024 and has held it in 10 quarters since. The position peaked at $15.3M in Q3 2024. 118 funds tracked by Wall St. Rank hold CTNM as of Q3 2026.

  • Sectoral Asset Management held 689,587 shares of Contineum Therapeutics worth $9.25M as of Q3 2026.
  • Sectoral Asset Management sold 38,000 Contineum Therapeutics shares in Q3 2026, an estimated $566K.
  • Contineum Therapeutics made up 5.88% of Sectoral Asset Management's portfolio in Q3 2026, its #2 holding.
  • Sectoral Asset Management first reported a position in Contineum Therapeutics in Q2 2024 and has held it in 10 quarters since.
  • Sectoral Asset Management's Contineum Therapeutics position peaked at $15.3M in Q3 2024.
  • 118 funds tracked by Wall St. Rank held Contineum Therapeutics as of Q3 2026.

Based on Sectoral Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.